CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.68% | -90.65% | -36.98% | -27.88% | -44.70% |
| Total Depreciation and Amortization | 0.20% | 0.48% | 1.82% | 2.44% | 5.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,794.37% | 784.24% | -73.89% | -85.87% | -130.39% |
| Change in Net Operating Assets | -1,452.29% | 84.71% | 57.50% | 8.92% | 626.67% |
| Cash from Operations | 16.82% | 97.55% | -6.24% | -19.57% | -32.17% |
| Capital Expenditure | -1.83% | 3.69% | 0.39% | -2.43% | 8.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -358.95% | -114.15% | 23.70% | 99.06% | 99.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 45.05% | 77.51% | -0.33% | -55.11% | -280.18% |
| Cash from Investing | 22.88% | 46.80% | 0.91% | 56.59% | 63.55% |
| Total Debt Issued | -59.63% | 43.12% | 39.31% | -42.26% | -38.92% |
| Total Debt Repaid | -20.43% | -253.04% | -227.85% | 18.73% | 41.55% |
| Issuance of Common Stock | 9.14% | -13.26% | -15.84% | -21.35% | 30.32% |
| Repurchase of Common Stock | 95.07% | 95.36% | 95.86% | 94.97% | -46.28% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.71% | -2.29% | -3.84% | -5.64% | -7.69% |
| Other Financing Activities | -100.00% | 415.38% | 110.00% | 133.96% | 112.94% |
| Cash from Financing | -335.24% | 2.40% | 26.43% | -76.38% | -142.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.91% | 135.48% | 39.17% | 104.93% | 107.51% |